BrainStorm Cell Therapeutics
BCLI
#10400
Rank
S$8.58 M
Marketcap
S$0.78
Share price
0.00%
Change (1 day)
-63.27%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -S$15.06 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$15.08 Million, an increase over its 2023 earnings that were of -S$22.31 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$15.06 Million-0.14%
2024 -S$15.08 Million-32.39%
2023 -S$22.31 Million-29.18%
2022 -S$31.5 Million-0.74%
2021 -S$31.73 Million-23.12%
2020 -S$41.27 Million36.8%
2019 -S$30.17 Million66.71%
2018 -S$18.1 Million181.66%
2017 -S$6.43 Million-0.6%
2016 -S$6.47 Million-41.31%
2015 -S$11.02 Million-8.22%
2014 -S$12 Million89.74%
2013 -S$6.33 Million42.27%
2012 -S$4.45 Million-12.45%
2011 -S$5.08 Million63.04%
2010 -S$3.12 Million35.52%
2009 -S$2.3 Million-48.99%
2008 -S$4.51 Million-44.39%
2007 -S$8.1 Million
2005 -S$4.2 Million-91.44%
2004 -S$49.02 Million94007.62%
2003 -S$0.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
S$12.82 B-86,455.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-S$0.98 Billion 6,468.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-S$1.03 Billion 6,805.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$2.47 B-16,731.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$26.8 M-280.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-S$0.34 Billion 2,131.73%๐Ÿ‡บ๐Ÿ‡ธ USA